Unilateral Relapsing Primary Angiitis of the CNS: An Entity Suggesting Differences in the Immune Response Between the Cerebral Hemispheres.
Journal
Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388
Informations de publication
Date de publication:
04 03 2021
04 03 2021
Historique:
received:
11
08
2020
accepted:
22
10
2020
entrez:
6
1
2021
pubmed:
7
1
2021
medline:
29
10
2021
Statut:
epublish
Résumé
To determine whether studying patients with strictly unilateral relapsing primary angiitis of the CNS (UR-PACNS) can support hemispheric differences in immune response mechanisms, we reviewed characteristics of a group of such patients. We surveiled our institution for patients with UR-PACNS, after characterizing one such case. We defined UR-PACNS as PACNS with clinical and radiographic relapses strictly recurring in 1 brain hemisphere, with or without hemiatrophy. PACNS must have been biopsy proven. Three total cases were identified at our institution. A literature search for similar reports yielded 4 additional cases. The combined 7 cases were reviewed for demographic, clinical, imaging, and pathologic trends. The median age at time of clinical onset among the 7 cases was 26 years (range 10-49 years); 5 were male (71%). All 7 patients presented with seizures. The mean follow-up duration was 7.5 years (4-14.1 years). The annualized relapse rate ranged between 0.2 and 1. UR-PACNS involved the left cerebral hemisphere in 5 of the 7 patients. There was no consistent relationship between the patient's dominant hand and the diseased side. When performed (5 cases), conventional angiogram was nondiagnostic. CSF examination showed nucleated cells and protein levels in normal range in 3 cases and ranged from 6 to 11 cells/μL and 49 to 110 mg/dL in 4 cases, respectively. All cases were diagnosed with lesional biopsy, showing lymphocytic type of vasculitis of the small- and medium-sized vessels. Patients treated with steroids alone showed progression. Induction therapy with cyclophosphamide or rituximab followed by a steroid sparing agent resulted in the most consistent disease remission. Combining our 3 cases with others reported in the literature allows better clinical understanding about this rare and extremely puzzling disease entity. We hypothesize that a functional difference in immune responses, caused by such discrepancies as basal levels of cytokines, asymmetric distribution of microglia, and differences in modulation of the systemic immune functions, rather than a structural antigenic difference, between the right and left brain may explain this phenomenon, but this is speculative.
Identifiants
pubmed: 33402525
pii: 8/2/e936
doi: 10.1212/NXI.0000000000000936
pmc: PMC7862090
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
Neurol Neuroimmunol Neuroinflamm. 2019 Feb 01;6(2):e538
pubmed: 30800721
Neurology. 2002 Jan 22;58(2):327-8
pubmed: 11805272
Ann Rheum Dis. 2009 Mar;68(3):310-7
pubmed: 18413444
Ann Intern Med. 2009 May 19;150(10):670-80
pubmed: 19451574
J Neurol. 2011 Sep;258(9):1714-6
pubmed: 21416209
Neuroimmunomodulation. 2005;12(3):189-94
pubmed: 15905628
Genome Biol. 2020 Mar 9;21(1):61
pubmed: 32151270
Neuroscience. 2003;116(3):639-47
pubmed: 12573707
Arthritis Rheumatol. 2014 May;66(5):1315-26
pubmed: 24782189
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
Heliyon. 2019 Jan 09;5(1):e01086
pubmed: 30671556
Stroke. 2012 Jul;43(7):1890-6
pubmed: 22550051
J Neurol Sci. 2016 Sep 15;368:32-4
pubmed: 27538597
Medicine (Baltimore). 2015 May;94(21):e738
pubmed: 26020379
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Int Rev Neurobiol. 2002;52:303-23
pubmed: 12498109
J Neuroimmunol. 2005 Jan;158(1-2):14-25
pubmed: 15589033
Neurologist. 2009 Sep;15(5):285-8
pubmed: 19741437
Ann Neurol. 2004 Jun;55(6):840-4
pubmed: 15174018
Neuron. 2009 May 28;62(4):494-509
pubmed: 19477152
Brain. 2009 Feb;132(Pt 2):544-57
pubmed: 19039009
Acta Neuropathol. 2006 Sep;112(3):305-16
pubmed: 16783554
Brain. 2005 Mar;128(Pt 3):454-71
pubmed: 15689357
Brain Res Brain Res Rev. 1992 May-Aug;17(2):101-7
pubmed: 1393189
Proc Natl Acad Sci U S A. 1982 Aug;79(16):5097-100
pubmed: 6956919
Neurology. 1998 Mar;50(3):731-5
pubmed: 9521265
Eur Neurol. 2010;64(2):74-9
pubmed: 20606451
Neurology. 1959 Sep;9:599-609
pubmed: 13812692
N Engl J Med. 2010 Jul 15;363(3):221-32
pubmed: 20647199